Tianjin Medical Journal ›› 2024, Vol. 52 ›› Issue (12): 1286-1291.doi: 10.11958/20240531
• Clinical Research • Previous Articles Next Articles
ZHOU Xiufen1(), LIU Hui2, CHEN Hong1, ZHAO Zongbo2,△(
)
Received:
2024-05-01
Revised:
2024-06-25
Published:
2024-12-15
Online:
2024-12-17
Contact:
△E-mail:ZHOU Xiufen, LIU Hui, CHEN Hong, ZHAO Zongbo. Clinical significance of changes in GLI and peripheral blood indicators in SAP patients[J]. Tianjin Medical Journal, 2024, 52(12): 1286-1291.
CLC Number:
组别 | n | 性别(男/女) | 年龄/岁 | 吸烟史 | 饮酒史 | |||||
---|---|---|---|---|---|---|---|---|---|---|
对照组 | 421 | 257/164 | 65.52±8.94 | 176(41.8) | 131(31.1) | |||||
研究组 | 129 | 71/58 | 67.02±10.06 | 63(48.8) | 35(27.1) | |||||
χ2或t | 1.480 | 1.611 | 1.987 | 0.744 | ||||||
组别 | 基础疾病 | |||||||||
高血压 | 糖尿病 | 高脂血症 | 冠心病 | 房颤 | ||||||
对照组 | 266(63.2) | 89(21.1) | 38(9.0) | 28(6.7) | 46(10.9) | |||||
研究组 | 89(69.0) | 36(27.9) | 19(14.7) | 12(9.3) | 22(17.1) | |||||
χ2 | 1.456 | 2.575 | 3.457 | 1.029 | 3.422 |
Tab.1 Comparison of baseline data between the study group and the control group
组别 | n | 性别(男/女) | 年龄/岁 | 吸烟史 | 饮酒史 | |||||
---|---|---|---|---|---|---|---|---|---|---|
对照组 | 421 | 257/164 | 65.52±8.94 | 176(41.8) | 131(31.1) | |||||
研究组 | 129 | 71/58 | 67.02±10.06 | 63(48.8) | 35(27.1) | |||||
χ2或t | 1.480 | 1.611 | 1.987 | 0.744 | ||||||
组别 | 基础疾病 | |||||||||
高血压 | 糖尿病 | 高脂血症 | 冠心病 | 房颤 | ||||||
对照组 | 266(63.2) | 89(21.1) | 38(9.0) | 28(6.7) | 46(10.9) | |||||
研究组 | 89(69.0) | 36(27.9) | 19(14.7) | 12(9.3) | 22(17.1) | |||||
χ2 | 1.456 | 2.575 | 3.457 | 1.029 | 3.422 |
组别 | n | 梗死部位 | |||||||
---|---|---|---|---|---|---|---|---|---|
前循环 | 后循环 | 前后循环 | |||||||
对照组 | 421 | 257(61.0) | 112(26.6) | 52(12.4) | |||||
研究组 | 129 | 83(64.3) | 25(19.4) | 21(16.3) | |||||
χ2 | 3.390 | ||||||||
组别 | 病因分型 | ||||||||
SAO | LAA | CE | SOE | SUE | |||||
对照组 | 133(31.6) | 131(31.1) | 83(19.7) | 40(9.5) | 34(8.1) | ||||
研究组 | 48(37.2) | 36(27.9) | 29(22.5) | 10(7.8) | 6(4.7) | ||||
χ2 | 3.578 |
Tab.2 Comparison of infarct site and etiological classification between the two groups
组别 | n | 梗死部位 | |||||||
---|---|---|---|---|---|---|---|---|---|
前循环 | 后循环 | 前后循环 | |||||||
对照组 | 421 | 257(61.0) | 112(26.6) | 52(12.4) | |||||
研究组 | 129 | 83(64.3) | 25(19.4) | 21(16.3) | |||||
χ2 | 3.390 | ||||||||
组别 | 病因分型 | ||||||||
SAO | LAA | CE | SOE | SUE | |||||
对照组 | 133(31.6) | 131(31.1) | 83(19.7) | 40(9.5) | 34(8.1) | ||||
研究组 | 48(37.2) | 36(27.9) | 29(22.5) | 10(7.8) | 6(4.7) | ||||
χ2 | 3.578 |
组别 | n | GLI/[(mmol/L)2/(h·d)] | CD4+/CD8+ | |||
---|---|---|---|---|---|---|
对照组 | 421 | 3.38±1.26 | 1.77±0.48 | |||
研究组 | 129 | 7.64±2.39 | 1.27±0.32 | |||
t | 19.412** | 13.589** | ||||
组别 | NLR | RDW/% | NGAL/(μg/L) | |||
对照组 | 2.45±0.74 | 12.53±3.42 | 109.50±21.63 | |||
研究组 | 5.02±1.54 | 13.96±4.26 | 126.28±20.63 | |||
t | 18.374** | 3.480** | 7.791** |
Tab.3 Comparison of laboratory indicators between the study group and the control group
组别 | n | GLI/[(mmol/L)2/(h·d)] | CD4+/CD8+ | |||
---|---|---|---|---|---|---|
对照组 | 421 | 3.38±1.26 | 1.77±0.48 | |||
研究组 | 129 | 7.64±2.39 | 1.27±0.32 | |||
t | 19.412** | 13.589** | ||||
组别 | NLR | RDW/% | NGAL/(μg/L) | |||
对照组 | 2.45±0.74 | 12.53±3.42 | 109.50±21.63 | |||
研究组 | 5.02±1.54 | 13.96±4.26 | 126.28±20.63 | |||
t | 18.374** | 3.480** | 7.791** |
变量 | β | SE | Wald χ2 | P | OR | OR 95%CI |
---|---|---|---|---|---|---|
GLI | 1.430 | 0.225 | 40.358 | <0.001 | 4.178 | 2.688~6.495 |
CD4+/CD8+ | -2.393 | 0.749 | 10.198 | 0.001 | 0.091 | 0.021~0.397 |
NLR | 2.703 | 0.472 | 32.803 | <0.001 | 14.921 | 5.917~37.626 |
RDW | 0.004 | 0.074 | 0.003 | 0.954 | 1.004 | 0.868~1.161 |
NGAL | 0.021 | 0.014 | 2.431 | 0.119 | 1.021 | 0.955~1.049 |
常数项 | -16.070 | 3.092 | 27.011 | <0.001 | 0.000 |
Tab.4 Multivariate Logistic regression analysis of SAP in patients with acute cerebral infarction
变量 | β | SE | Wald χ2 | P | OR | OR 95%CI |
---|---|---|---|---|---|---|
GLI | 1.430 | 0.225 | 40.358 | <0.001 | 4.178 | 2.688~6.495 |
CD4+/CD8+ | -2.393 | 0.749 | 10.198 | 0.001 | 0.091 | 0.021~0.397 |
NLR | 2.703 | 0.472 | 32.803 | <0.001 | 14.921 | 5.917~37.626 |
RDW | 0.004 | 0.074 | 0.003 | 0.954 | 1.004 | 0.868~1.161 |
NGAL | 0.021 | 0.014 | 2.431 | 0.119 | 1.021 | 0.955~1.049 |
常数项 | -16.070 | 3.092 | 27.011 | <0.001 | 0.000 |
组别 | n | GLI/[(mmol/L)2/(h·d)] | CD4+/CD8+ | |||
---|---|---|---|---|---|---|
低危组 | 52 | 6.41±1.71 | 1.39±0.28 | |||
中高危组 | 77 | 8.47±2.43 | 1.19±0.32 | |||
t | 5.623** | 3.566** | ||||
组别 | NLR | RDW/% | NGAL/(μg/L) | |||
低危组 | 3.93±0.90 | 12.11±3.74 | 118.36±14.65 | |||
中高危组 | 5.76±1.44 | 15.21±4.15 | 131.63±22.38 | |||
t | 8.894** | 4.326** | 4.070** |
Tab.5 Comparison of laboratory indicators between the low-risk group and the middle- high risk group
组别 | n | GLI/[(mmol/L)2/(h·d)] | CD4+/CD8+ | |||
---|---|---|---|---|---|---|
低危组 | 52 | 6.41±1.71 | 1.39±0.28 | |||
中高危组 | 77 | 8.47±2.43 | 1.19±0.32 | |||
t | 5.623** | 3.566** | ||||
组别 | NLR | RDW/% | NGAL/(μg/L) | |||
低危组 | 3.93±0.90 | 12.11±3.74 | 118.36±14.65 | |||
中高危组 | 5.76±1.44 | 15.21±4.15 | 131.63±22.38 | |||
t | 8.894** | 4.326** | 4.070** |
变量 | β | SE | Wald χ2 | P | OR | OR 95%CI |
---|---|---|---|---|---|---|
GLI | 0.579 | 0.163 | 12.687 | <0.001 | 1.784 | 1.297~2.453 |
CD4+/CD8+ | -2.666 | 1.079 | 6.107 | 0.013 | 0.070 | 0.008~0.576 |
NLR | 1.143 | 0.291 | 15.453 | <0.001 | 3.135 | 1.773~5.542 |
RDW | 0.175 | 0.075 | 5.371 | 0.020 | 1.191 | 1.027~1.381 |
NGAL | 0.032 | 0.014 | 5.298 | 0.021 | 1.032 | 1.005~1.061 |
常数项 | -12.158 | 2.912 | 17.432 | <0.001 | 0.000 |
Tab.6 Multivariate Logistic regression analysis of the severity of SAP patients
变量 | β | SE | Wald χ2 | P | OR | OR 95%CI |
---|---|---|---|---|---|---|
GLI | 0.579 | 0.163 | 12.687 | <0.001 | 1.784 | 1.297~2.453 |
CD4+/CD8+ | -2.666 | 1.079 | 6.107 | 0.013 | 0.070 | 0.008~0.576 |
NLR | 1.143 | 0.291 | 15.453 | <0.001 | 3.135 | 1.773~5.542 |
RDW | 0.175 | 0.075 | 5.371 | 0.020 | 1.191 | 1.027~1.381 |
NGAL | 0.032 | 0.014 | 5.298 | 0.021 | 1.032 | 1.005~1.061 |
常数项 | -12.158 | 2.912 | 17.432 | <0.001 | 0.000 |
组别 | n | GLI/[(mmol/L)2/(h·d)] | CD4+/CD8+ | |||
---|---|---|---|---|---|---|
预后良好组 | 86 | 7.18±2.33 | 1.31±0.34 | |||
预后不良组 | 43 | 8.56±2.27 | 1.17±0.25 | |||
t | 3.197** | 2.367* | ||||
组别 | NLR | RDW/% | NGAL/(μg/L) | |||
预后良好组 | 4.43±1.20 | 13.01±4.18 | 123.59±19.26 | |||
预后不良组 | 6.19±1.48 | 15.87±3.78 | 131.65±22.40 | |||
t | 7.254** | 3.777** | 2.119* |
Tab.7 Comparison of laboratory indicators between the good prognosis group and the poor prognosis group
组别 | n | GLI/[(mmol/L)2/(h·d)] | CD4+/CD8+ | |||
---|---|---|---|---|---|---|
预后良好组 | 86 | 7.18±2.33 | 1.31±0.34 | |||
预后不良组 | 43 | 8.56±2.27 | 1.17±0.25 | |||
t | 3.197** | 2.367* | ||||
组别 | NLR | RDW/% | NGAL/(μg/L) | |||
预后良好组 | 4.43±1.20 | 13.01±4.18 | 123.59±19.26 | |||
预后不良组 | 6.19±1.48 | 15.87±3.78 | 131.65±22.40 | |||
t | 7.254** | 3.777** | 2.119* |
变量 | β | SE | Wald χ2 | P | OR | OR 95%CI |
---|---|---|---|---|---|---|
GLI | 0.194 | 0.098 | 3.875 | 0.041 | 1.214 | 1.001~1.471 |
CD4+/CD8+ | -0.849 | 0.776 | 1.197 | 0.274 | 0.428 | 0.094~1.957 |
NLR | 0.827 | 0.192 | 18.604 | <0.001 | 2.287 | 1.570~3.331 |
RDW | 0.149 | 0.066 | 5.012 | 0.025 | 1.160 | 1.019~1.322 |
NGAL | 0.008 | 0.012 | 0.518 | 0.472 | 1.008 | 0.986~1.032 |
常数项 | -8.815 | 2.453 | 12.914 | <0.001 | 0.000 | - |
Tab.8 Multivariate Logistic regression analysis of the prognosis of patients with SAP
变量 | β | SE | Wald χ2 | P | OR | OR 95%CI |
---|---|---|---|---|---|---|
GLI | 0.194 | 0.098 | 3.875 | 0.041 | 1.214 | 1.001~1.471 |
CD4+/CD8+ | -0.849 | 0.776 | 1.197 | 0.274 | 0.428 | 0.094~1.957 |
NLR | 0.827 | 0.192 | 18.604 | <0.001 | 2.287 | 1.570~3.331 |
RDW | 0.149 | 0.066 | 5.012 | 0.025 | 1.160 | 1.019~1.322 |
NGAL | 0.008 | 0.012 | 0.518 | 0.472 | 1.008 | 0.986~1.032 |
常数项 | -8.815 | 2.453 | 12.914 | <0.001 | 0.000 | - |
指标 | AUC(95%CI) | 截断值 | 敏感度/ % | 特异度/ % | 约登 指数 |
---|---|---|---|---|---|
GLI | 0.686(0.599~0.765) | 8.00 (mmol/L)2/(h·d) | 62.79 | 75.58 | 0.384 |
NLR | 0.820(0.742~0.882) | 5.60 | 65.12 | 88.37 | 0.535 |
RDW | 0.679(0.592~0.759) | 12.80% | 83.72 | 47.67 | 0.314 |
联合检测 | 0.851(0.778~0.908) | - | 79.07 | 79.07 | 0.581 |
Tab.9 Predictive values of GLI, NLR and RDW for the prognosis of patients with SAP
指标 | AUC(95%CI) | 截断值 | 敏感度/ % | 特异度/ % | 约登 指数 |
---|---|---|---|---|---|
GLI | 0.686(0.599~0.765) | 8.00 (mmol/L)2/(h·d) | 62.79 | 75.58 | 0.384 |
NLR | 0.820(0.742~0.882) | 5.60 | 65.12 | 88.37 | 0.535 |
RDW | 0.679(0.592~0.759) | 12.80% | 83.72 | 47.67 | 0.314 |
联合检测 | 0.851(0.778~0.908) | - | 79.07 | 79.07 | 0.581 |
[1] | WANG Y, CHEN Y, CHEN R, et al. Development and validation of a nomogram model for prediction of stroke-associated pneumonia associated with intracerebral hemorrhage[J]. BMC Geriatr, 2023, 23(1):633. doi:10.1186/s12877-023-04310-5. |
[2] | BOUDDHARA T, PERSONDEK L, ABLAH E, et al. Post-stroke pneumonia: Factors associated with readmission within 90 days of stroke discharge[J]. J Stroke Cerebrovasc Dis, 2023, 32(10):107276. doi:10.1016/j.jstrokecerebrovasdis.2023.107276. |
[3] | ALI A N, HOWE J, MAJID A, et al. The economic cost of stroke-associated pneumonia in a UK setting[J]. Top Stroke Rehabil, 2018, 25(3):214-223. doi:10.1080/10749357.2017.1398482. |
[4] | HRYCIW B N, GHOSSEIN J, ROCHWERG B, et al. Glycemic variability as a prognostic factor for mortality in patients with critical illness:a systematic review and Meta-analysis[J]. Crit Care Explor, 2024, 6(1):e1025. doi:10.1097/CCE.0000000000001025. |
[5] | WU Z, ZHENG Y, SHENG J, et al. CD3+CD4-CD8- (double-negative) T cells in inflammation,immune disorders and cancer[J]. Front Immunol, 2022, 13(1):816005. doi:10.3389/fimmu.2022.816005. |
[6] | 乔坤艳, 刘韦娜, 郑晓雅, 等. 布鲁氏菌病患者外周血白细胞及血小板参数的变化及临床意义[J]. 天津医药, 2024, 52(4):391-396. |
QIAO K Y, LIU W N, ZHENG X Y, et al. Changes and clinical significance of white blood cell and platelet parameters of peripheral blood in Brucellosis patients[J]. Tianjin Med J, 2024, 52(4):391-396. doi:10.11958/20230779. | |
[7] | 郭露露, 高飞, 张涛, 等. 血清中性粒细胞明胶酶相关脂质运载蛋白在老年急性肾损伤高风险患者的预测价值[J]. 中华老年医学杂志, 2023, 42(3):316-321. |
GUO L L, GAO F, ZHANG T, et al. Predictive value of serum neutrophil gelatinase-associated lipocalin for acute kidney injury in high-risk elderly patients[J]. Chin J Geriatr, 2023, 42(3):316-321. doi:10.3760/cma.j.issn.0254-9026.2023.03.014. | |
[8] | 呼彪彪, 胡书群, 许铁, 等. 早期血糖不稳定指数对院外心脏骤停患者预后的评估价值[J]. 临床急诊杂志, 2023, 24(4):201-206. |
HU B B, HU S Q, XU T, et al. Prognostic value of early glycemic lability index in patients with out-of-hospital cardiac arrest[J]. J Clin Emerg, 2023, 24(4):201-206. doi:10.13201/j.issn.1009-5918.2023.04.006. | |
[9] | HAGGAG H, HODGSON C. Clinimetrics:modified rankin scale (mRS)[J]. J Physiother, 2022, 68(4):281. doi:10.1016/j.jphys.2022.05.017. |
[10] | LI D, LIU Y, JIA Y, et al. Association between malnutrition and stroke-associated pneumonia in patients with ischemic stroke[J]. BMC Neurol, 2023, 23(1):290. doi:10.1186/s12883-023-03340-1. |
[11] | LIU Z, LIN X, LIN W, et al. A J-shaped curve relationship between baseline fasting blood glucose and 1-year stroke recurrence in non-diabetic patients with acute cerebral infarction in Xi'an, China:A multicenter observational cohort study[J]. Front Neurol, 2021, 12:698793. doi:10.3389/fneur.2021.698793. |
[12] | DENG Y, WU S, LIU J, et al. The stress hyperglycemia ratio is associated with the development of cerebral edema and poor functional outcome in patients with acute cerebral infarction[J]. Front Aging Neurosci, 2022, 14(1):936862. doi:10.3389/fnagi.2022.936862. |
[13] | LIN J, CAI C, XIE Y, et al. Acute glycemic variability and mortality of patients with acute stroke:a Meta-analysis[J]. Diabetol Metab Syndr, 2022, 14(1):69. doi:10.1186/s13098-022-00826-9. |
[14] | LEE S H, MO H J, KIM Y, et al. Predicting role of prestroke glycemic variability estimated by glycated albumin for reperfusion and prognosis after endovascular treatment[J]. Cerebrovasc Dis, 2023, 52(1):44-51. doi:10.1159/000524481. |
[15] | SMITH M J, PENNY T, PHAM Y, et al. Neuroprotective action of tacrolimus before and after onset of neonatal hypoxic-ischaemic brain injury in rats[J]. Cells, 2023, 12(22):2659. doi:10.3390/cells12222659. |
[16] | YOSHIMURA A, OHYAGI M, ITO M. T cells in the brain inflammation[J]. Adv Immunol, 2023, 157:29-58. doi:10.1016/bs.ai.2022.10.001. |
[17] | CONG L, GAO H, MA W. Prognostic relationship between peripheral red cell distribution width and acute cerebral infarction in patients with rtPA thrombolysis[J]. Neurotox Res, 2020, 38(1):211-218. doi:10.1007/s12640-020-00186-0. |
[18] | ZHAI M, CAO S, WANG X, et al. Increased neutrophil-to-lymphocyte ratio is associated with unfavorable functional outcomes in acute pontine infarction[J]. BMC Neurol, 2022, 22(1):445. doi:10.1186/s12883-022-02969-8. |
[19] | 张花平, 宋贺, 张博, 等. 外周血NLR、sTREM-1、PCT水平对老年卒中患者相关性肺炎的诊断价值[J]. 解放军医药杂志, 2020, 32(4):72-75. |
ZHANG H P, SONG H, ZHANG B, et al. Diagnostic values of peripheral blood NLR,sTREM-1 and PCT levels in elderly patients with stroke-associated pneumonia[J]. Med & Pharm J Chin PLA, 2020, 32(4):72-75. doi:10.3969/j.issn.2095-140X.2020.04.018. | |
[20] | CHEN Y, FU Y, WANG S, et al. Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years[J]. Cardiovasc Diabetol, 2022, 21(1):252. doi:10.1186/s12933-022-01668-5. |
[21] | JABERI S A, COHEN A, D'SOUZA C, et al. Lipocalin-2:Structure,function,distribution and role in metabolic disorders[J]. Biomed Pharmacother, 2021, 142(1):112002. doi:10.1016/j.biopha.2021.112002. |
[1] | YANG Min, PAN Yansha, ZHANG Changling, CHEN Hongying, GUO Qulian, LIU Wenjun. Correlation analysis of baseline data, early treatment response and prognosis in children with acute lymphoblastic leukemia [J]. Tianjin Medical Journal, 2024, 52(9): 954-958. |
[2] | WANG Xinbo, LUO Bingqing, SHI Yubao, ZHANG Ye, XI Jiangwei. Expression of LncRNA LINC00342 and miR-203a-3p in colorectal cancer tissue and their relationship with prognosis [J]. Tianjin Medical Journal, 2024, 52(9): 971-976. |
[3] | DAI Yao, FANG Xiang, HUANG Kang, FENG Jie, LIU Min, WU Songbai. Clinical curative effect of HAT therapy on septic shock [J]. Tianjin Medical Journal, 2024, 52(8): 825-829. |
[4] | ZHANG Xiyou, GUO Yidan, ZHANG Chunxia, ZHOU Xiaoling, JIA Meng, SHI Zhihua, LUO Yang. Clinical research of the correlation between hyperkalemia and adverse outcome events in elderly patients with maintenance hemodialysis [J]. Tianjin Medical Journal, 2024, 52(8): 840-844. |
[5] | MAN Yi, XU Ya, HE Xiancheng, SONG Shaofeng, LIU Aiguo. Relationship between expression levels of EGFR, Ki-67, P53 and CTC and the prognosis of triple negative breast cancer [J]. Tianjin Medical Journal, 2024, 52(8): 862-867. |
[6] | LI Li, CAO Shuming, YANG Zhongping, HU Ruomei. Effects of fish collagen oligopeptide on operative prognosis of patients with emergency complex hand trauma [J]. Tianjin Medical Journal, 2024, 52(8): 868-871. |
[7] | LUO Yanran, SHI Xiaofei, HAN Lei, ZHANG Bei, WEN Luyao. Research progress of dermatomyositis-related autoantibodies in interstitial lung disease [J]. Tianjin Medical Journal, 2024, 52(7): 704-708. |
[8] | XUE Jing, YUAN Xiaodong, XING Aijun, WANG Lianhui, MA Qian, FU Yongshan, ZHANG Pingshu. Relationship between sleep-wake biorhythm and prognosis in patients with acute ischemic stroke [J]. Tianjin Medical Journal, 2024, 52(6): 614-619. |
[9] | YE Zhaoyang, MA Jianzhong, LI Houjun, WEI Kunpeng. Relationship between peripheral blood TLR4, IL-1β and NLR and the progression and prognosis of acute pancreatitis [J]. Tianjin Medical Journal, 2024, 52(6): 648-652. |
[10] | LYU Mengna, LI Jianbin, WU Rui. Early predictors of the severity of COVID-19 in patients with autoinflammatory diseases [J]. Tianjin Medical Journal, 2024, 52(5): 528-531. |
[11] | WU Jikun, XU Rongdi, XU Jinghan, WANG Le, CONG Hongliang. Validation and comparison of 6 common model scores in predicting long-term prognosis in patients with NSTEMI [J]. Tianjin Medical Journal, 2024, 52(5): 541-547. |
[12] | WANG Ningfang, ZHAO Chongshan, LIU Fang, ZHAO Penghao, ZHANG Dongdong, CAI Zhuowen, CAI Fangfang. The detection and clinical significance of microparticles derived from lymphocytes in patients with multiple myeloma [J]. Tianjin Medical Journal, 2024, 52(4): 409-415. |
[13] | ZHANG Wenchao, YANG Xuehui, YIN Tao, WANG Ruijian, ZHANG Mengmeng. The relationship between plasma sCD163/sTWEAK ratio and prognosis in patients with spontaneous acute cerebral hemorrhage [J]. Tianjin Medical Journal, 2024, 52(3): 297-301. |
[14] | DING Bo, GONG Jieqin, SHEN Likui. Relationship between serum indexes, pathogenetic condition and prognosis in patients with acute ischemic stroke [J]. Tianjin Medical Journal, 2024, 52(2): 172-176. |
[15] | GAO Guangren, FENG Lianrong, FU Jinguo, GUO Run, NIU Heping, LI Fengpeng, ZHANG Qianyu, ZHANG Jun. Characteristics of myocardial injury in patients with acute myocardial infarction complicated with pleural effusion and its influence on long-term prognosis [J]. Tianjin Medical Journal, 2024, 52(2): 197-200. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||